Billiontoone, Inc.

BillionToOne Reports First Quarter 2026 Results and Raises 2026 Revenue Guidance

BillionToOne Launches Unity Confirm™: A category-defining test that bridges the gap between screening and invasive diagnostics

BillionToOne to Report First Quarter 2026 Financial Results on May 6, 2026

BillionToOne Appoints Dr. Allen Chen as Vice President of Medical Affairs and Clinical Development, Oncology

BillionToOne Reports Fourth Quarter and Full Year 2025 Results and Raises 2026 Revenue Guidance